Labshake search
Citations for Stemcell Technologies :
101 - 150 of 759 citations for Recombinant Mouse Regenerating Islet derived 3 Alpha His tagged since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2022Quote: ... and Neurotrophin-3 (NT-3; 20 ng/ml, Stemcell technologies) and the culture medium was changed every 3-4 days ...
-
bioRxiv - Biophysics 2020Quote: ... Patient-derived GBM cells were plated in NeuroCult NS-A serum-free medium (StemCell Technologies, Vancouver, BC, Canada) supplemented with 20 ng/ml of epidermal- and 10 ng/ml of fibroblast-growth factor (Sigma-Aldrich) ...
-
bioRxiv - Cancer Biology 2023Quote: ... MLL-AF10 patient-derived xenograft (PDX) cells were cultured in IMDM medium supplemented with 20% BIT9500 (STEMCELL Technologies), human cytokines ...
-
bioRxiv - Genomics 2023Quote: ... The human iPSC-derived cardiomyocytes (hiPSC-CMs) were reprogrammed using the STEMdiff™ Cardiomyocyte Differentiation Kit (STEMCELL Technologies) as recommended by the manufacturer ...
-
bioRxiv - Immunology 2024Quote: PSC-derived ECs were differentiated from all the PSC lines using the STEMdiff Endothelial Differentiation Kit (StemCell Technologies) according to the manufacturer’s protocol ...
-
bioRxiv - Immunology 2023Quote: ... Primary B cells were isolated from spleens of 2–3 month old C57Bl/6N mice by negative selection with EasySep™ Mouse B Cell Isolation Kit (# 19854, STEMCELL Technologies).
-
bioRxiv - Bioengineering 2021Quote: ... 1 ng/mL human recombinant Leukemia Inhibitory Factor (LIF, STEMCELL Technologies, 78055.1) and 10 ng/mL human recombinant Epidermal Growth Factor (EGF ...
-
bioRxiv - Bioengineering 2021Quote: ... 1 ng/mL human recombinant Leukemia Inhibitory Factor (LIF, STEMCELL Technologies, 78055.1) and 10 ng/mL human recombinant Epidermal Growth Factor (EGF ...
-
bioRxiv - Bioengineering 2021Quote: ... 10 ng/mL human recombinant Leukemia Inhibitory Factor (LIF, STEMCELL Technologies, 78055.1), and 10 ng/mL GDNF ...
-
bioRxiv - Bioengineering 2021Quote: ... 20 ng/mL human recombinant Epidermal Growth Factor (EGF, STEMCELL Technologies, 78006.1), 10 ng/mL human recombinant Leukemia Inhibitory Factor (LIF ...
-
bioRxiv - Bioengineering 2021Quote: ... supplemented with 10 ng μL-1 recombinant human IL-2 (StemCell Technologies) and activated with the ImmunoCult Human CD3/CD28 T Cell Activator (StemCell Technologies) ...
-
bioRxiv - Synthetic Biology 2021Quote: ... and 20 ng/ml human recombinant bFGF (Stem Cell Technologies cat# 78003). For 10 gBlocks pool ...
-
bioRxiv - Immunology 2020Quote: ... and 5 ng/mL recombinant human IL-15 (StemCell Technologies, Cat # 78031). Recombinant SARS-CoV-2 receptor binding domain was coated onto MaxiSorp 96-well plates (Thermo Scientific ...
-
bioRxiv - Cancer Biology 2022Quote: ... 10 ng/ml human recombinant basic fibroblast growth factor (STEMCELL Technologies, 78003.1), and 0.679 U/ml heparin (Sigma ...
-
bioRxiv - Bioengineering 2023Quote: ... with the addition of Human Recombinant Interleukin 2 (STEMCELL Technologies, Cat# 78036.3). To prepare 3 mg/ml collagen-I gel ...
-
bioRxiv - Molecular Biology 2023Quote: ... supplemented with 20 ng/ml recombinant human EGF (STEMCELL Technologies, cat# 78006). For passaging ...
-
bioRxiv - Cancer Biology 2024Quote: ... and 10 ng/ml human recombinant G-CSF (Stemcell Technologies, Vancouver, Canada). Tazemetostat (EPZ-6438 ...
-
bioRxiv - Molecular Biology 2019Quote: ... Definitive endoderm (DE) was derived from a culture of H1 hESCs using the StemDiff Definitive Endoderm kit (StemCell Technologies).
-
bioRxiv - Microbiology 2020Quote: Human iPSC (XCL-1)98-derived neural progenitor cells (hNPCs) were purchased commercially (StemCell Technologies, Cat #70901, Lot #17080) and maintained up to ten passages according to the manufacturer’s instructions ...
-
bioRxiv - Neuroscience 2023Quote: Differentiation of iPSCs into iPSC-derived hematopoietic progenitor cells (iHPCs) was carried out using STEMdiffTM Hematopoietic kit (STEMCELL Technologies) as previously described (4 ...
-
bioRxiv - Cancer Biology 2021Quote: ... supplemented with human recombinant epidermal growth factor (20ng/mL: STEMCELL Technologies, Cat#78006), basic fibroblast growth factor (20ng/mL ...
-
bioRxiv - Cancer Biology 2019Quote: ... 20 ng/mL Recombinant Human Epidermal Growth Factor (EGF) (StemCell Technologies, Cat 02633), 10 ng/mL Recombinant Human Basic Fibroblast Growth Factor (Bfgf ...
-
bioRxiv - Bioengineering 2021Quote: ... and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2, STEMCELL Technologies, 78003.1) in RPMI 1640 for 2 days ...
-
bioRxiv - Bioengineering 2021Quote: ... and 10 ng/mL human recombinant Epidermal Growth Factor (EGF, STEMCELL Technologies, 78006.1), and passaged using TrypLE™ Express Enzyme.
-
bioRxiv - Bioengineering 2021Quote: ... and 10 ng/mL human recombinant Epidermal Growth Factor (EGF, STEMCELL Technologies, 78006.1), and passaged using TrypLE™ Express Enzyme.
-
bioRxiv - Bioengineering 2021Quote: ... and 100ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2, STEMCELL Technologies, 78003.1) for 2 days ...
-
bioRxiv - Bioengineering 2021Quote: ... 1 ng/mL human recombinant Fibroblast Growth Factor 2 (FGF2, STEMCELL Technologies, 78003.1), 20 ng/mL animal component-free human recombinant Glial Cell Derived Neurotrophic Factor (GDNF ...
-
bioRxiv - Neuroscience 2024Quote: ... human recombinant shh (C24II) (cat# 78065.1) (all from STEMCELL Technologies, Tullamarine, VIC, Australia). See table S2 for antibodies used for ICC.
-
bioRxiv - Bioengineering 2024Quote: ... supplemented with 10 ng/mL of Human Recombinant IL-2 (STEMCELL TECHNOLOGIES, #78220) and ImmunoCult™ Human CD3/CD28 T Cell Activator (STEMCELL TECHNOLOGIES ...
-
bioRxiv - Synthetic Biology 2023Quote: ... supplemented with Human Recombinant IL-2 (12.5 ng/mL) (Stemcell Technologies, Cat.#78036), with initial seeding at 1×106 alive cells/mL ...
-
bioRxiv - Synthetic Biology 2023Quote: ... supplemented with Human Recombinant IL-2 (12.5 ng/mL) (Stemcell Technologies, Cat.#78036), IL-7 (5 ng/mL ...
-
bioRxiv - Bioengineering 2024Quote: ... supplemented with 10 ng/mL recombinant IL-2 (StemCell Technologies Inc, cat#78036.1). T cells were removed from CD3/CD28 plate coating after 48 hours of incubation and moved to uncoated wells ...
-
bioRxiv - Developmental Biology 2022Quote: Day 15 H9 hESC-derived enteric crestospheres were dissociated into single cells (accutase, Stemcell Technologies, 07920, 30 min, 37 °C), resuspended in ENC medium and were transferred into 384-well plates ...
-
bioRxiv - Biophysics 2023Quote: NK-92 cells (purchased from ATCC CRL-2407) are cultured for three weeks prior to measurements in in Alpha-MEM medium (Stemcell Technologies) with 15% fetal calf serum (Sigma) ...
-
bioRxiv - Cancer Biology 2019Quote: ... 10 ng/mL Recombinant Human Basic Fibroblast Growth Factor (Bfgf) (StemCell Technologies, Cat 02634), 2 μg/mL Heparin (StemCell Technologies ...
-
bioRxiv - Bioengineering 2021Quote: ... and 40 ng/mL animal component-free human recombinant Activin A (STEMCELL Technologies, 78132) for 12 days with media changes every other day ...
-
bioRxiv - Developmental Biology 2022Quote: ... supplemented with 30 ng/mL human recombinant epidermal growth factor (rhEGF) (STEMCELL Technologies 78006) and filtered through a 40 μm filter (Fisherbrand™ 22-363-547 ...
-
bioRxiv - Biophysics 2023Quote: ... with the addition of Human Recombinant Interleukin 2 (IL-2, STEMCELL Technologies Inc., USA).
-
bioRxiv - Bioengineering 2022Quote: ... and interleukin-3 (IL-3; 1 ng/mL, first day only; Stemcell Technologies; Canada). Cell density was maintained between 0.7-2×106 cells/mL by daily feeding with fresh expansion medium.
-
bioRxiv - Cell Biology 2021Quote: Pluripotent hiPSC lines derived from control and FOP fibroblasts (Matsumoto et al., 2013; Spencer et al., 2014) were cultured in mTeSR1 medium (StemCell Technologies) on irradiated SNL feeder cells (McMahon & Bradley ...
-
bioRxiv - Neuroscience 2024Quote: All iPS cell lines (CRISPR/Cas9-edited isogenic clones and TSC patient-derived lines) were routinely expanded in culture and maintained using mTeSR1 medium (STEMCELL Technologies) and cell culture surfaces pre-coated with Matrigel (Corning ...
-
bioRxiv - Neuroscience 2023Quote: NPC (iPSC-derived) patterning toward forebrain neuron fate was conducted using a commercially available kit (STEMdiff Forebrain Neuron Differentiation Kit, STEMCELL Technologies). Cells were maintained in forebrain neuron differentiation medium for 6 days before being dissociated into a single-cell solution and plated onto either Poly-L-Lysine- and Laminin-coated glassware/ Geltrex-coated plasticware at varying densities (6 well plate – 5.2x104 cells/cm2 ...
-
bioRxiv - Neuroscience 2023Quote: hiPSC line (IMR90-4, WiCell) derived from a healthy donor and fully characterized was cultured with mTeSRTM Plus Medium (STEMCELL Technologies) on growth factor reduced matrigel-coated 6-well plates (Corning ...
-
bioRxiv - Neuroscience 2023Quote: Human iPSC-derived microglia (iMGL) were generated from human iPSC-derived hematopoietic progenitors using the STEMdiff Microglia Differentiation Kit and Microglia Maintenance Kit (STEMCELL Technologies) according to manufacturer instructions ...
-
bioRxiv - Microbiology 2023Quote: ... Primary airway cells derived from single patient sources were first expanded on plastic in Pneumacult-Ex Plus medium (Cat No. 05040, StemCell Technologies), then seeded (3.3 × 104 cells / well ...
-
bioRxiv - Genomics 2020Quote: ... 3 µM CHIR99021 (Stemcell Technologies), 1 µM PD0325901 (Stemcell Technologies) ...
-
bioRxiv - Immunology 2024Quote: ... + 3 µM CHIR9902 (Stemcell Technologies) + 10 µM SB-431542 (Stemcell Technologies ...
-
bioRxiv - Developmental Biology 2023Quote: ... 3 μM CHIR99021 (STEMCELL Technologies), 1 μM PD0325901 (STEMCELL Technologies) ...
-
bioRxiv - Immunology 2021Quote: ... from healthy buffy coat donors and incubated overnight with human recombinant Interleukin 15 (STEMCELL Technologies). NK cells were incubated with immune complexes ...
-
bioRxiv - Immunology 2020Quote: Leukopak-derived peripheral blood mononuclear cells (PBMCs) purchased from LifeSouth Community Blood Centers were debulked with RosetteSep CD8+ enrichment kits (Stem Cell Technologies), and then separated into an enriched fraction of PBMC using a Ficoll gradient ...